| Association of microRNAs and YRNAs with platelet function D Kaudewitz, P Skroblin, LH Bender, T Barwari, P Willeit, R Pechlaner, ... Circulation research 118 (3), 420-432, 2016 | 198 | 2016 |
| In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation PCJ Armstrong, PD Leadbeater, MV Chan, NS Kirkby, JA Jakubowski, ... Journal of Thrombosis and Haemostasis 9 (3), 552-561, 2011 | 191 | 2011 |
| Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of … X Wang, CE Hagemeyer, JD Hohmann, E Leitner, PC Armstrong, F Jia, ... Circulation 125 (25), 3117-3126, 2012 | 178 | 2012 |
| Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2 S Lucotti, C Cerutti, M Soyer, AM Gil-Bernabé, AL Gomes, PD Allen, ... The Journal of clinical investigation 129 (5), 1845-1862, 2019 | 152 | 2019 |
| Antiplatelet actions of statins and fibrates are mediated by PPARs FY Ali, PCJ Armstrong, ARA Dhanji, AT Tucker, MJ Paul-Clark, JA Mitchell, ... Arteriosclerosis, thrombosis, and vascular biology 29 (5), 706-711, 2009 | 152 | 2009 |
| GPIIb/IIIa inhibitors: from bench to bedside and back to bench again PC Armstrong, K Peter Thrombosis and haemostasis 107 (05), 808-814, 2012 | 140 | 2012 |
| Assessment of platelet function in the laboratory P Harrison Hämostaseologie 29 (01), 25-31, 2009 | 106 | 2009 |
| Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs B Ahmetaj-Shala, NS Kirkby, R Knowles, M Al’Yamani, S Mazi, Z Wang, ... Circulation 131 (7), 633-642, 2015 | 98 | 2015 |
| Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy PCJ Armstrong, ARA DHANJI, AT Tucker, JA Mitchell, TD Warner Journal of Thrombosis and Haemostasis 8 (3), 613-615, 2010 | 92 | 2010 |
| Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage P Vulliamy, S Gillespie, PC Armstrong, HE Allan, TD Warner, K Brohi Proceedings of the National Academy of Sciences 116 (35), 17444-17449, 2019 | 86 | 2019 |
| Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2 PCJ Armstrong, NJ Truss, FY Ali, AA Dhanji, I Vojnovic, ZNM Zain, ... Journal of Thrombosis and Haemostasis 6 (11), 1933-1943, 2008 | 79 | 2008 |
| Newly formed reticulated platelets undermine pharmacokinetically short-lived antiplatelet therapies PC Armstrong, T Hoefer, RB Knowles, AT Tucker, MA Hayman, ... Arteriosclerosis, thrombosis, and vascular biology 37 (5), 949-956, 2017 | 76 | 2017 |
| Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing MV Chan, PCJ Armstrong, F Papalia, NS Kirkby, TD Warner Platelets 22 (7), 485-494, 2011 | 70 | 2011 |
| Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond) M Crescente, L Menke, MV Chan, PC Armstrong, TD Warner British journal of pharmacology 176 (8), 988-999, 2019 | 68 | 2019 |
| GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors H Hu, PCJ Armstrong, E Khalil, YC Chen, A Straub, M Li, J Soosairajah, ... PloS one 6 (4), e19190, 2011 | 58 | 2011 |
| Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists? TD Warner, PCJ Armstrong, NP Curzen, JA Mitchell Heart 96 (21), 1693-1694, 2010 | 58 | 2010 |
| Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness PCJ Armstrong, AR Dhanji, NJ Truss, ZNM Zain, AT Tucker, JA Mitchell, ... Thrombosis and haemostasis 102 (10), 772-778, 2009 | 52 | 2009 |
| Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse PC Armstrong, NS Kirkby, ZN Zain, M Emerson, JA Mitchell, TD Warner PLoS One 6 (5), e20062, 2011 | 46 | 2011 |
| Cyclooxygenases and the cardiovascular system JA Mitchell, NS Kirkby, B Ahmetaj-Shala, PC Armstrong, M Crescente, ... Pharmacology & Therapeutics 217, 107624, 2021 | 45 | 2021 |
| 96-well plate-based aggregometry MV Chan, PC Armstrong, TD Warner Platelets 29 (7), 650-655, 2018 | 41 | 2018 |
Timothy D. WarnerProfessor of Vascular InflammationVerified email at qmul.ac.uk
